Alex Azar’s job hop from drugmaker Eli Lilly tothe Trump administration reflects ever-deepening ties between the pharmaceuticalindustry and the federal government.

A Kaiser Health News analysis shows that hundreds of people haveglided through the “revolving door” that connects the drug industryto Capitol Hill and to the Department of Health and HumanServices.

Azar was confirmed Wednesday as HHS secretary, joiningother former drug industry alumni in top positions.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.